miR-21 activates the EGFR/AKT signaling pathway via targeting tumor suppressor genes such as PTEN, PDCD4, APAF1, TPM1, TIMP3, RECK, FOXO1 and SPRY240. Here, AKT1 is linked to neoplasm.